Period of time： 2014年5期
Publisher： Informa Healthcare
Founded in： 1991
Total resources： 179
ISSN： 1354-3776
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Therapeutic Patents,volume 23,issue 5
Menu
The America Invents Act implementation
By Hollinger Susanne in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.
Access to resources
Recommend
Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.PTEN modulators: a patent review
By Boosani Chandra S,Agrawal Devendra K in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.By Belluti Federica,Rampa Angela,Gobbi Silvia,Bisi Alessandra in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.Sigma receptor modulators: a patent review
By Collina Simona,Gaggeri Raffaella,Marra Annamaria,Bassi Andrea,Negrinotti Sara,Negri Francesca,Rossi Daniela in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.AMPA receptor positive allosteric modulators: a patent review
By Pirotte Bernard,Francotte Pierre,Goffin Eric,de Tullio Pascal in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.mGluR2 positive allosteric modulators: a patent review (2009 – present)
By Trabanco Andrés A,Cid José María in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.BACE2 as a new diabetes target: a patent review (2010 – 2012)
By Southan Christopher in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.PSMA-targeted dendrimers: a patent evaluation (WO2012078534)
By Akhtar Naveed H,Osborne Joseph R,Fareedy Shoaib B,Tagawa Scott T in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158)
By Li Nian-Guang,Tang Yu-Ping,Duan Jin-Ao in (2013)
Expert Opinion on Therapeutic Patents,volume 23,issue 5 , Vol. 23, Iss. 5, 2013-05 , pp.